NCT02300506View on ClinicalTrials.gov

Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma

CompletedOBSERVATIONAL
Enrollment

507

Participants

Timeline

Start Date

January 10, 2014

Primary Completion Date

July 10, 2016

Study Completion Date

July 10, 2016

Conditions
Malignant Glioma
Interventions
OTHER

No intervention

Trial Locations (2)

Unknown

Osaka

Tokyo

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02300506 - Post-Marketing Surveillance of Long-Term Observation of Gliadel Wafer-Investigation of Vital Prognosis in Patients With High Grade Glioma | Biotech Hunter | Biotech Hunter